Article

A Novel Gene Expression Signature-Based on B-Cell Proportion to Predict Prognosis of Patients with Lung Adenocarcinoma

2021-07-06

Abstract excerpt

<h4>Background: </h4> This study aimed to develop a reliable immune signature based on B-cell proportion to predict the prognosis and benefit of immunotherapy in LUAD. <h4>Methods: </h4>: The proportion of immune cells in the TCGA-LUAD dataset was estimated using MCP-counter. The Least Absolute Shrinkage and Selector Operation was used to identify a prognostic signature and validated in an independent cohort. We u...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 215afacd-5cc4-55e2-b039-0640e7ff0c14
DOI: 10.21203/rs.3.rs-585268/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Novel Gene Expression Signature-Based on B-Cell Proportion to Predict Prognosis of Patients with Lung AdenocarcinomaDOI 10.21203/rs.3.rs-585268/v1Read

Immune signature-based risk stratification and prediction of immune checkpoint inhibitor's efficacy for lung adenocarcinoma.Semantic proximity Read

Exploration of Tumor Mutation Burden Combined with Immune Infiltrates in the Prognosis of Lung AdenocarcinomaSemantic proximity Read

A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma.Semantic proximity Read

Profiles of immune infiltration in lung adenocarcinoma and their clinical significant: A gene‐expression–based retrospective studySemantic proximity Read

Construction of a novel prognostic model for evaluation of immune infiltration and immunotherapy in lung adenocarcinomaSemantic proximity Read

Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinomaSemantic proximity Read

Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.Semantic proximity Read

Construction and validation of a novel immune and tumor mutation burden-based prognostic model in lung adenocarcinoma.Semantic proximity Read

Development and validation of an immune‐related prognostic signature in lung adenocarcinomaSemantic proximity Read

Identification of a immune-related genes signature for survival prediction in stage I lung adenocarcinomaSemantic proximity Read

A Novel Inflammatory-Related Gene Signature Based Model for Risk Stratification and Prognosis Prediction in Lung AdenocarcinomaSemantic proximity Read

Immune Score Closely Associated With Tumor Microenvironment as A Prognostic Factor in Lung AdenocarcinomaSemantic proximity Read